Abstract
Headaches associated with menstruation are often resistant to abortive and preventative medications. We performed an open-label study in 20 female migraineurs, employing oral sumatriptan perimenstrually as short-term prophylaxis of menstrual migraine. In 126 sumatriptan-treated cycles, headache was absent in 52.4% and reduced in severity by 50% or greater in 42%. Breakthrough headaches were rare and significantly reduced in severity compared with baseline headaches.
Original language | English (US) |
---|---|
Pages (from-to) | 307-309 |
Number of pages | 3 |
Journal | Neurology |
Volume | 51 |
Issue number | 1 |
DOIs | |
State | Published - Jul 1998 |
ASJC Scopus subject areas
- Clinical Neurology